Correspondence


Nature Biotechnology 26, 860 - 861 (2008)
doi:10.1038/nbt0808-860

Guidelines for reporting the use of mass spectrometry in proteomics

Chris F Taylor1,2, Pierre-Alain Binz3,4, Ruedi Aebersold5, Michel Affolter6, Robert Barkovich7, Eric W Deutsch8, David M Horn9, Andreas Hühmer10, Martin Kussmann6, Kathryn Lilley11, Marcus Macht12, Matthias Mann13, Dieter Müller14, Thomas A Neubert15, Janice Nickson16, Scott D Patterson17, Roberto Raso18, Kathryn Resing19, Sean L Seymour20, Akira Tsugita21, Ioannis Xenarios22, Rong Zeng23 & Randall K Julian, Jr24

  1. European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK.
  2. NERC Environmental Bioinformatics Centre, Mansfield Road, Oxford, OX1 3SR, UK.
  3. Swiss Institute of Bioinformatics, Proteome Informatics Group, Rue Michel-Servet 1, CH-1211 Geneva 4, Switzerland.
  4. GeneBio SA, 25 Av. de Champel, CH-1206 Geneva, Switzerland.
  5. Institute for Molecular Systems Biology, ETH Zurich, HPT E 78, Wolfgang-Pauli-Str. 16, 8093 Zürich, Switzerland.
  6. Nestlé Research Center, Nestec Ltd., Vers-chez-Les-Blanc, 1000 Lausanne 26, Switzerland.
  7. Affimetrix, Inc., 3420 Central Expressway, Santa Clara, California 95051, USA.
  8. Institute for Systems Biology, 1441 N. 34th Street, Seattle, Washington 98103, USA.
  9. Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, California 95051, USA.
  10. Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose, California 95134, USA.
  11. Cambridge Centre for Proteomics, University of Cambridge, Cambridge, Cambridgeshire, CB2 1QW, UK.
  12. Bruker Daltonik GmbH, Bremen, Germany.
  13. Department of Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, Am Klopferspitz 18, D-82152 Martinsried, Germany.
  14. Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Pathway Profiling, WSJ-088.702, CH-4056 Basel, Switzerland.
  15. Skirball Institute of Biomolecular Medicine and Department of Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
  16. Pathways, DECS, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK.
  17. Amgen Inc., Molecular Sciences, One Amgen Center Drive MS 38-3-A, Thousand Oaks, California 91320-1799, USA.
  18. Kratos Analytical (Shimadzu), Wharfside, Trafford Wharf Road, Manchester, M17 1GP UK.
  19. Department of Chemistry & Biochemistry, University of Colorado, Boulder, Colorado 80309-0215, USA.
  20. Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
  21. Proteomics Research Laboratory, Tokyo Rikakikai Co., Tsukuba, Japan.
  22. Swiss Institute of Bioinformatics, Vital-IT group, Quartier Sorge – Bàtiment Génopole, CH-1015 Lausanne, Switzerland.
  23. Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China.
  24. Indigo BioSystems, Inc., 111 Congressional Blvd., Suite 160, Carmel, Indiana 46032, USA.

Correspondence to: Pierre-Alain Binz3,4 e-mail: Pierre-Alain.Binz@isb-sib.ch

To the editor:

A paper in last August's issue presented the overall Minimum Information about a Proteomics Experiment (MIAPE) reporting guidelines for the field of proteomics1. We would like to draw the community's attention to the MIAPE Mass Spectrometry (MIAPE-MS) module, which specifies the minimum information that should be provided when reporting the use of mass spectrometry in a proteomics experiment (Box 1). Developed through a joint effort between the Mass Spectrometry working group of the Human Proteome Organisation's Proteomics Standards Initiative (HUPO-PSI; http://www.psidev.info/) and the wider proteomics community, MIAPE-MS constitutes one part of the MIAPE documentation system. It comprises a checklist of information that should be provided about mass spectrometry performed in the course of generating a data set that is submitted to a public repository or when such an experimental step is reported in a scientific publication (for instance, in the materials and methods section). MIAPE-MS specifies neither the format in which information should be transferred nor the structure of any repository or document. However, HUPO-PSI is not developing the MIAPE modules in isolation; several compatible data exchange standards are now well established and supported both by public databases and by data processing software in proteomics.

The modern mass spectrometer is a rather complex instrument with many operational parameters; the data sets generated are similarly complex and often rather voluminous. Therefore, MIAPE-MS does not prescribe that all of that information be captured; and given the diversity of instruments currently available, the utility of such detail is clearly open to question. However, it is possible to specify parameters that are representative of the way in which the mass spectrometer was used, to contextualize the data generated and thereby enable a better-informed process of assessment and interpretation.

The guidelines (see Supplementary Guidelines and Supplementary Table 1 online) cover both the operation of a mass spectrometer and the generation of mass spectra from the 'raw' data. They do not cover the delivery of sample to the mass spectrometer or the interpretation of spectra by search engines; those details are captured in separate MIAPE modules, the latest versions of which can be obtained from the MIAPE home page. Note also that MIAPE-MS does not cover all the available components of a mass spectrometer (e.g., some of the less frequently used ion sources); subsequent versions may have expanded coverage, as will almost certainly be the case for all MIAPE modules.

ADVERTISEMENT

These guidelines will evolve as circumstances dictate. The most recent version of MIAPE-MS is available at http://www.psidev.info/miape/ms/ and the content is replicated here as supplementary information (Supplementary Guidelines and Supplementary Table 1). To contribute, or to track the process to remain 'MIAPE compliant', browse to the website at http://www.psidev.info/miape/.

Note: Supplementary information is available on the Nature Biotechnology website.



Top

Reference

  1. Taylor, C.F. et al. Nat. Biotechnol. 25, 887–893 (2007). | Article | PubMed | ISI | ChemPort |